Quince Therapeutics, Inc. (QNCX)
NASDAQ: QNCX · Real-Time Price · USD
32.41
+1.15 (3.68%)
At close: Aug 13, 2026, 4:00 PM EDT
32.50
+0.09 (0.28%)
After-hours: Aug 13, 2026, 7:34 PM EDT
Quince Therapeutics Market Cap
Quince Therapeutics has a market cap or net worth of $31.7 million as of August 13, 2026. Its market cap has decreased by -67.75% in one year.
Market Cap
31.70M
Enterprise Value
13.94M
1-Year Change
-67.75%
Ranking
Category
Stock Price
$32.41
ChartMarket Cap Chart
Since May 9, 2019, Quince Therapeutics's market cap has decreased from $855.57M to $31.70M, a decrease of -96.30%. That is a compound annual growth rate of -36.45%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2026 | 31.70M | -83.01% |
| Dec 31, 2025 | 186.53M | 126.70% |
| Dec 31, 2024 | 82.28M | 82.80% |
| Dec 29, 2023 | 45.01M | 95.46% |
| Dec 30, 2022 | 23.03M | -93.89% |
| Dec 31, 2021 | 377.06M | -53.99% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 9, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Lantern Pharma | 33.56M |
| Estrella Immunopharma | 31.18M |
| NanoViricides | 30.98M |
| Genenta Science | 30.67M |
| Lite Strategy | 30.47M |
| Actinium Pharmaceuticals | 30.31M |
| BriaCell Therapeutics | 29.62M |
| IGC Pharma | 29.43M |